Log In
Print
BCIQ
Print
Print this Print this
 

AndroGel (AndroGel PD)

Also known as: testosterone gel (Androgel-DHT)

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
Description1% testosterone gel
Molecular Target Androgen receptor
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsBoost low testosterone in elderly men; Manage blood sugar levels in men with Type II diabetes and hypogonadism (low testosterone or low T); Treat constitutional delay in growth and puberty (CDGP); Treat geriatric hypogonadism; Treat hypogonadism; Treat hypogonadism in AIDS; Treat male testosterone deficiency; Treat primary or secondary hypogonadism in male adolescents
Regulatory Designation

Partner

AbbVie Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today